Britain could potentially withhold some payments to the European Union if a deal to help the country leave the bloc doesn’t happen before next year.
As part of a Brexit transition deal, Britain is set to pay the EU between €35 and €39 billion (US$41-US$46 billion) over the coming decades. The country is due to leave the bloc in March 2019.
But Brexit Secretary Dominic Raab on Wednesday, August 29, told members of Britain’s upper house of Parliament that not all of the payments were a legal obligation, and that the country could actually delay sending funds without a deal.
“I don’t think it could be safely assumed on anyone’s side that the financial settlement that has been agreed [on] as part of the withdrawal bill would then just be paid, in precisely the same shape or speed or rate, if there was no deal,” he said, according to Reuters.
Last month, Brussels rejected the UK’s proposals on how to govern London’s access to the European market after Brexit, saying that British Prime Minister Theresa May’s latest plan would take away the EU’s “decision-making autonomy.”
The UK government had published a 98-page whitepaper that detailed plans for an enhanced “equivalence” model, which would build on an existing system that countries like the US and Singapore use to simplify their access to the bloc.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Fortnite Returns to Apple’s U.S. App Store After Five-Year Ban
May 21, 2025 by
CPI
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas